TY - CHAP A1 - Danijela Štrbac A2 - Katja Goričar A3 - Viljem Kovač A4 - Vita Dolžan ED1 - Sonia Maciá Y1 - 2020-11-11 PY - 2020 T1 - Current Mesothelioma Treatment and Future Perspectives N2 - Mesothelioma is an aggressive cancer with very poor survival and lack of treatment options. This book, written by a diverse panel of experts, presents a description of the most relevant topics on epidemiology, diagnosis, biomarkers, and treatment updates, including interesting discussion on molecular mechanisms, prognostic features, and novel therapies that are either approved or under clinical development for this challenging disease. It also discusses and explains genetic biomarkers, as there may be a role for some nuclear regulatory genes and proteins in development of mesothelioma, although targeted therapies so far have had limited impact. BT - Mesothelioma SP - Ch. 3 UR - https://doi.org/10.5772/intechopen.94246 DO - 10.5772/intechopen.94246 SN - 978-1-83968-155-4 PB - IntechOpen CY - Rijeka Y2 - 2021-01-25 ER -